1/19/2021 6:02:32 AM
Spelman College, IDEAYA Partner For Professional Development Of Next Generation Of Female African American Leaders
1/11/2021 6:03:00 AM
IDEAYA Biosciences Submits IND Application For MAT2A Development Candidate IDE397 With The U.S. FDA
1/5/2021 6:06:14 AM
IDEAYA Biosciences Doses First Patient In A Phase 1 Combination Study Of IDE196 And Crizotinib
12/14/2020 6:01:28 AM
IDEAYA Biosciences Announces Addition To NASDAQ Biotechnology Index
11/12/2020 6:04:49 AM
IDEAYA Biosciences Q3 Loss Per Share $0.17 Vs Loss $0.54 Last Year
9/24/2020 6:01:26 AM
IDEAYA Biosciences Expands Clinical Trial Collaboration And Supply Agreement With Pfizer
8/12/2020 6:03:24 AM
IDEAYA Biosciences Q2 Loss Per Share $0.59 Vs Loss $1.30 Last Year
8/4/2020 6:17:30 AM
IDEAYA Announces HSR Clearance Of GSK Partnership In Synthetic Lethality
7/16/2020 6:03:05 AM
IDEAYA Announces Clinical Protocol Criteria Met For Cohort Expansion In Skin Melanoma For Phase 2 GNAQ/11 Basket Trial
7/9/2020 6:01:47 AM
IDEAYA Biosciences Announces First-Patient-In In Phase 1 Combination Study Of IDE196 And Binimetinib
6/30/2020 6:01:07 AM
IDEAYA Appoints Garret Hampton To Board
6/17/2020 10:40:46 PM
IDEAYA Biosciences Prices Public Offering Of 6.67 Mln Shares At $15.00/shr
6/16/2020 4:06:30 PM
IDEAYA Announces Proposed Public Offering Of Common Stock